Ramón
Lecumberri Villamediana
Consultor Médico
Hospital Universitario de Salamanca
Salamanca, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Salamanca (19)
2024
-
A Simple Frailty Score Predicts Survival and Early Mortality in Systemic AL Amyloidosis
Cancers, Vol. 16, Núm. 9
2022
-
Prevention of venous thromboembolism in hematologic neoplasms: an expert consensus from SEHH–SETH
Clinical and Translational Oncology, Vol. 24, Núm. 5, pp. 770-783
-
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients
Leukemia and Lymphoma, Vol. 63, Núm. 3, pp. 538-550
-
Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled Trial
Thrombosis and Haemostasis, Vol. 122, Núm. 2, pp. 295-299
-
Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry
Viruses, Vol. 14, Núm. 2
2021
-
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Leukemia, Vol. 35, Núm. 1, pp. 245-249
2019
-
Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis
Leukemia, Vol. 33, Núm. 5, pp. 1256-1267
-
Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency
Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418
2018
-
Cancer-associated thrombosis: Beyond clinical practice guidelines-A multidisciplinary (SEMI-SEOM-SETH) expert consensus
TH Open, Vol. 2, Núm. 4, pp. e373-e386
2017
-
Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa
Emergencias, Vol. 29, Núm. 1, pp. 18-26
-
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation
American Journal of Medicine, Vol. 130, Núm. 4, pp. 482.e1-482.e9
2016
-
Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study
European Journal of Haematology, Vol. 97, Núm. 2, pp. 128-136
-
Short Leukocyte Telomere Length Is Associated with Cardioembolic Stroke Risk in Patients with Atrial Fibrillation
Stroke, Vol. 47, Núm. 3, pp. 863-865
2015
-
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry
Thrombosis Journal, Vol. 13, Núm. 1
2013
-
Multiple myeloma patients have a specific serum metabolomic profile that changes after achieving complete remission
Clinical Cancer Research, Vol. 19, Núm. 17, pp. 4770-4779
-
National consensus on the diagnosis, risk stratification and treatment of patients with pulmonary embolism
Archivos de Bronconeumologia, Vol. 49, Núm. 12, pp. 534-547
2008
-
AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms
Haematologica, Vol. 93, Núm. 5, pp. 729-734
2007
-
Antithrombin Cambridge II (A384S): An underestimated genetic risk factor for venous thrombosis
Blood, Vol. 109, Núm. 10, pp. 4258-4263
2003
-
Evaluation of the factor V HR2 haplotype as a risk factor for ischemic cerebrovascular disease
Haematologica, Vol. 88, Núm. 2, pp. 236-237